Ciliary Body and Choroid Melanoma, Small Size Completed Phase 2 Trials for Dacarbazine (DB00851)
Indication | Status | Phase |
---|---|---|
DBCOND0030836 (Ciliary Body and Choroid Melanoma, Small Size) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01100528 | Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance | Treatment |